Amarantus BioSciences announces close of convertible bridge note
Amarantus Biosciences, a biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic protein that addresses an underlying form of cell death […]
Say something
Tags: biotechnology, Board Member, cancer, Chemotherapy, chief investment officer, Chief utive Office of Serenity Pharmaceuticals, Director, health care technology, Healthcare devices, Joshua Kornberg, leading global pension fund advisors, Martin D. Cleary, Morgan Stanley, New York Stock Exchange, Oncogene Sciences, Parkinson's disease, pharmaceuticals, Prostate Cancer, radioactive seeds, Samuel Herschkowitz, The Lightstone Group, treatment for Parkinson's Disease, treatment of prostate cancer, USD, Vice President
-
-
Flipkart Health+ App Launched
06-04-2022
